Editors in Conversation

American Society for Microbiology

Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more.

The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.

Subscribe Listen in podnod RSS feed Show website

20 episodes
Updated Friday

Episodes20

Newest first

Friday · 30 min
Technology and Discovery in Modern Microbiology
New imaging and measurement approaches are revealing previously hidden aspects of microbial life, challenging long-held assumptions and creating opportunities to answer questions that were once out of reach. Marvin Whiteley, Heran Darwin and Jeffrey Moffitt talk about how technological innovation is transforming microbiology. Guests: Heran Darwin, Ph.D. - NYU Grossman School of Medicine Jeffrey Moffitt, Ph.D. - Boston Children's Research This episode of Editors in Conversation is brought to you by mBio® and hosted by mBio Editor in Chief, Marvin Whiteley, Ph.D. Visit journals.asm.org/journal/mbio to read articles and/or submit a manuscript. Receive up to 50% off fees when you publish in mBio® or any of the ASM journals by becoming an ASM member. Sign up at asm.org/joinasm.
July 19 · 28 min
Cyclospora In The Lab
It starts out with a couple of stomach twinges, maybe a little nausea, maybe some sharp pains, and then… before you know it, you are running to the closest toilet with which you become very, very familiar. Cyclospora causes frequent watery diarrhea with sometime "explosive" bowel movements, but is typically a relatively rare cause of infectious diarrhea. However, the U.S. is in the midst of one of the largest documented cyclosporiasis outbreaks. How does one acquire this parasite? What are the risks? And – most importantly for our audience – how does the lab approach diagnosis? Guests: Daniel Rhoads, M.D. Bobbi Pritt, M.D. Marc Couturier, Ph.D., D(ABMM) Links: This episode is brought to you by the Journal of Clinical Microbiology. Visit asm.org/jcm to browse issues and/or submit a manuscript. If you plan to publish in JCM, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.
July 10 · 29 min
Next Gen Careers in Clinical Microbiology
So, you think you want a career in clinical microbiology? This field demands more than technical skill—it's driven by curiosity, growth, and the confidence to lead. From mastering diagnostics to pushing innovation and mentoring the next generation, success comes to those who keep evolving. In this episode, we explore the many paths into the field—and spotlight the Laboratory Director role through a candid conversation between early- and mid-career leaders, sharing the real highs, lows, and advice for those ready to step up. Watch this episode: https://youtu.be/p992HyDcm-M Guests: Amanda Roth, Ph.D. Janiece Glover, Ph.D., MS Links: This episode is brought to you by the Journal of Clinical Microbiology. Visit asm.org/jcm to browse issues and/or submit a manuscript. If you plan to publish in JCM, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.
July 1 · 43 min
AI and Antibiotic Discovery
Artificial intelligence is revolutionizing the world in many ways. One of the most exciting applications of artificial intelligence is in the area of drug discovery. Particularly the discovery of antimicrobial molecules that are in the environment or even hidden within our own body. Today, we discuss some of the uses of artificial intelligence in the discovery of antimicrobials with an outstanding expert in the field. Topics discussed: How artificial intelligence can help the discovery of new antimicrobial moieties Antibiotic discovery and challenges to bring molecules to the clinic The implications for artificial intelligence and infectious diseases in particularly in the discovery of antibiotics. Guest: César de la Fuente, Ph.D., FRSB, Presidential Associate Professor at the University of Pennsylvania. Director, Machine Biology Group. This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at https://asm.org/aac. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit https://asm.org/joinasm to sign up. Visit https://asm.org/aac to browse issues and/or submit a manuscript. Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates. Get the audio only podcast at https://asm.org/eic.
April 24 · 40 min
Why Your Lab QC Might Be Missing Critical Errors
Accurate AST results are the backbone of diagnostic stewardship, yet routine quality control (QC) might be missing subtle shifts that skew your hospital's annual antibiogram. By examining a real-world "silent failure" in daptomycin testing, we explore how lab-driven data is essential to the AMR crisis response and why the human eye—and traditional QC bugs—aren't always enough to catch technical drifts. This session breaks down the importance of LIS rules, alert fatigue, and the future of automated susceptibility testing. Guests: Laurel J. Glaser, M.D., Ph.D. Rebekah Dumm, Ph.D. D(ABMM) Links: Leveraging patient data to detect systematic shifts in daptomycin susceptibility testing associated with reduced prescribing This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM) and Elitza (Elli) Theel, Ph.D., D(ABMM). Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.
April 11 · 40 min
Phage JS1: The Virus Breaking the Rules
In this episode, a fascinating new bacteriophage, JS1. While most contractile phages (which inject DNA like a spring-loaded syringe) are rigid and straight, JS1 sports a curved, flexible tail that may help it navigate the complex "canyons and valleys" of the bacterial cell wall. Watch this episode: https://youtu.be/eDGta8xc4_0 Guests: Sabrina Suhani, Ph.D., Graduate Student, Monash University, Australia Trevor Lithgow, Ph.D., Professor, Monash University's Biomedical Discovery Institute. Links: Staphylococcus species infected by a bacteriophage with a tail that is both curved and contractile This episode of Editors in Conversation is brought to you by mBio® and hosted by mBio Editor in Chief, Marvin Whiteley, Ph.D. Visit journals.asm.org/journal/mbio to read articles and/or submit a manuscript. Receive up to 50% off fees when you publish in mBio® or any of the ASM journals by becoming an ASM member. Sign up at asm.org/joinasm.
March 27 · 37 min
Urine-based Testing to Detect HPV
Is the future of cervical cancer screening non-invasive? Sharmila Manjeshwar, Ph.D. and Jeffrey Klausner M.D. MPH, discuss a breakthrough in HPV diagnostics: urine-based testing. While vaccination and clinical screening have reduced cervical cancer rates, participation has stalled due to barriers like healthcare access and the invasive nature of traditional clinician-collected samples. This conversation explores how novel high-volume urine concentration technology is changing the landscape, making screening more accessible, private, and efficient. Watch this episode: https://youtu.be/am7NvL1Y0g4 Guests: Sharmila Manjeshwar, Ph.D. Jeffrey Klausner M.D. MPH Links: Performance of a novel, urine-based test for the detection of cervical human papillomavirus infection This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM) and Elitza (Elli) Theel, Ph.D., D(ABMM). Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.
March 20 · 37 min
The Aerobiome - The Hidden Biology of Air
Most microbiome research focuses on soil, oceans, or hosts. But the atmosphere itself harbors diverse communities of bacteria and fungi that move between ecosystems. This episode explores a recent mBio study comparing airborne microbial communities above a subalpine forest and a grassland in Colorado. The conversation unpacks what the "aerobiome" is, how scientists actually sample microbes from the air, and why height, time of day, and season matter. The study reveals striking differences between fungi and bacteria, with fungi showing strong site-specific structure and environmental sensitivity, while bacteria appear more ubiquitous. They also discuss "vertical filtering," long-distance dispersal, and what these findings mean for pathogen spread, ecosystem connectivity, and climate change. The atmosphere is not empty space, it is an active conduit connecting microbial life across landscapes. Guests: Carolyn R. Cornell, Ph.D., Department of Agricultural BiologyColorado State University Jane E. Stewart, Ph.D., Department of Agricultural BiologyColorado State University Links: Spatiotemporal patterns of airborne microbial communities in forest and grassland ecosystems. This episode of Editors in Conversation is brought to you by mBio® and hosted by mBio Editor in Chief, Marvin Whiteley, Ph.D. This episode is brought to you by the mBio journal available at https://asm.org/mBio. If you plan to publish in mBio, ASM Members get up to 50% off publishing fees. Visit https://asm.org/joinasm to sign up. Visit https://asm.org/mBio to browse issues and/or submit a manuscript. Follow mBio on twitter at https://x.com/mbiojournal.
March 6 · 33 min
Harnessing MALDI-TOF for MICs
Matrix-assisted laser desorption ionization time of flight mass spectrometry (or MALDI) has revolutionized the clinical microbiology laboratory, enabling rapid, accurate and cheap identification of bacteria, yeast, moulds and mycobacteria. In most labs, it has become a verb (I maldi'ed it). But – can it replace our antimicrobial susceptibility tests? Let's find out! Guests: Dr. Frieder Schaumburg Niklas Wiesmann
February 27 · 44 min
Fungi in a Warming World: Climate, Candida auris, and the Next Microbial Frontier - with Arturo Casadevall, M.D., Ph.D.
In the inaugural episode of Editors in Conversation mBio edition, Marvin Whiteley speaks with Arturo Casadevall, infectious-disease physician-scientist, founding Editor in Chief of mBio, and a leading voice in fungal pathogenesis and scientific rigor. They explore how climate change may be reshaping the fungal kingdom, potentially eroding the thermal barrier that has historically protected humans from most fungal pathogens. Using Candida auris (C auris) as a case study, they discuss heat adaptation, antifungal resistance, and what climate change could mean for future outbreaks. The conversation also examines fungal pandemics in pop culture, the challenges of antifungal drug development, and the promise of vaccines and biotechnology. Fungi are both threat and ally in a changing world, and understanding them has never been more urgent. Guest: Arturo Casadevall, M.D., Ph.D. - Johns Hopkins Bloomberg Distinguished Professor, Infectious-disease physician-scientist, Founding Editor in Chief of mBio® Links: On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds Reflections on my 15 years as mBio editor in chief This episode of Editors in Conversation is brought to you by mBio® and hosted by mBio Editor in Chief, Marvin Whiteley, Ph.D. Visit journals.asm.org/journal/mbio to read articles and/or submit a manuscript. Receive up to 50% off fees when you publish in mBio® or any of the ASM journals by becoming an ASM member. Sign up at asm.org/joinasm.
February 7 · 50 min
Best AMR papers of 2025: A Collaboration between AAC and JID for IMARI
The Interdisciplinary Meeting of Antimicrobial Resistance and Innovation has launched! The first version of IMARI brought together researchers, clinicians, industry leaders and policymakers to address one of the greatest challenges in modern medicine: antimicrobial resistance" Check the highlights at IMARI.org and prepare for IMARI 2017 from January 27-29, 2027! The inaugural amazing conference took place in Las Vegas. This is the forst time that ASM and IDSA collaborate together in a scientific meeting. One of the sessions involved an unprecedent collaboration between two journals AAC and JID published by each society. To celebrate this achievement we had a session of the best AMR papers of 2025 for AAC and JID. This session will be presented here as apart of our series. Watch this episode: https://youtu.be/XRYl7863z34 Objectives: - Review the best papers and topics of AMR in 2025 form AAC and JID. - Discuss the context of each finding and contributions to the AMR community - Elaborate on the implications for AMR, novelties and how the field is advancing. Guests: - Ayesha Khan, Ph.D. Assistant Professor, Pathology & Laboratory Medicine and Associate Director, Division of Clinical Microbiology Biomedical & Translational Research Track. Principal Investigator, UC3P UCI Prime Pre-Health Pathways Program. - Madison Stellfox, M.D. Ph.D. Assistant Professor of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA. Links: Links: AAC A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp. https://doi.org/10.1128/aac.01627-24 JID Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam Against Metallo-β-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-based model https://doi.org/10.1093/infdis/jiaf567 AAC Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors https://doi.org/10.1128/aac.01614-24 JID Daptomycin-Loaded Nanocarriers Facilitate Synergistic Killing of Methicillin-Resistant Staphylococcus aureus via Lipid-Mediated Interactions and Targeting https://doi.org/10.1093/infdis/jiaf492 AAC Amoxicillin-non-susceptible Streptococcus pneumoniae causing invasive pneumonia: serotypes, clones, and clinical impact https://doi.org/10.1128/aac.00237-25 JID Blood Cultures Contain Populations of Genetically Diverse Candida albicans Strains that May Differ in Echinocandin Tolerance and Fitness https://doi.org/10.1093/infdis/jiaf495 AAC Antibiofilm activity of manogepix, ibrexafungerp, amphotericin B, rezafungin, and caspofungin against Candida spp. biofilms of reference and clinical strains https://doi.org/10.1128/aac.00137-25 JID Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates https://doi.org/10.1093/infdis/jiae438 AAC Emergence of antibiotic-specific Mycobacterium tuberculosis phenotypes during prolonged treatment of mice https://doi.org/10.1128/aac.01310-24 JID The Changing Paradigm in Infectious Diseases—Host-Directed Medicine: Implications for the Next Generation of ID Physicians https://doi.org/10.1093/infdis/jiaf497 JID Triggering Toll-Like Receptor 5 Signaling During Pneumococcal Superinfection Prevents the Selection of Antibiotic Resistance https://doi.org/10.1093/infdis/jiae239 IMARI Conference This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at https://asm.org/aac. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit https://asm.org/joinasm to sign up. Visit https://asm.org/aac to browse issues and/or submit a manuscript. Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates.
January 25 · 35 min
Green Labs
Climate change is one of the most pressing issues facing humanity – and is not a future problem. Changes to the Earth's climate driven by emission of greenhouse gases have led to glaciers shrinking, plant and animal geographic ranges shifting and historical droughts, wildfires and rainfall. What does all of this have to do with the clinical laboratory? Subscribe to Editors in Conversation on Apple Podcasts, Android, Spotify, or Email and never miss an episode. Guests: Dr. Joesph Wiencek, Director of Clinical Chemistry and Associate Professor at VUMC Andrea Prinzi, Ph.D., MPH, SM(ASCP), bioMérieux Links: The foundation for the microbiology laboratory's essential role in diagnostic stewardship: an ASM Laboratory Practices Subcommittee report Approaches to developing and implementing a molecular diagnostics stewardship program for infectious diseases: an ASM Laboratory Practices Subcommittee report Guiding antimicrobial stewardship through thoughtful antimicrobial susceptibility testing and reporting strategies: an updated approach in 2023 This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM). Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.
January 9 · 56 min
Rising Antimicrobial Resistance in The Microbial Universe
This is a special live recording of Editors in Conversation at the 2025 ASM Global Research Symposium in Bengaluru, India. We explore the evolving landscape of drug-resistant pathogens—from the intracellular survival strategies of Salmonella to the global rise of multidrug-resistant fungi like Candida auris. This conversation highlights the urgent need for integrated, One Health solutions to combat AMR across human, animal, and environmental domains. Watch this episode: https://youtu.be/G1KtS6MSjHs Topics discussed: The implications of the OneHealth approach for microbiology and public health. The connection between planetary science, human activity and the rise of multidrug-resistant pathogens. Illustrate with specific examples the major challenges to combat multidrug-resistant pathogens in a country like India. Guests: Anuradha Chowdhary, M.D., Ph.D. Professor, University of Delhi India, Vallabhbhai Patel Chest Institute. Head of National Reference Laboratory for Antimicrobial Resistance in Fungal Pathogens. New Delhi, India. Dipshikha Chakravortty, Ph.D. Astra Chair Professor, Department of Microbiology and Cell Biology India Institute of Science, Head of Molecular Pathogenesis Laboratory, Bengaluru, India. Links: ASM Global Research Symposium on the One Health Approach to Antimicrobial Resistance (AMR) This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal. Visit asm.org/aac to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.
Dec 19, 2025 · 58 min
Favorite Clinical Microbiology Papers of 2025
I almost can't believe that we are wrapping up yet another year on the podcast this month, which has been going strong for 6 years now! And it has been another exciting year in the world of Clin Micro as well with improvements and new assays available for some of our bread and butter tests, but the year also brought about significant developments in the application of AI and digital imaging, use of NGS methods, and probably some cool AST stuff in there too among other things, with many of these advancements published in JCM. And so, as has become customary for the last 6 years, for this episode, we will be sharing some of our favorite papers or more intriguing manuscripts published in the Journal this year. And I have to say, this is probably one of the hardest episodes to prep for because picking just on paper to talk about is an incredible difficult task! But, we are up to the challenge and we'll share those with you over the next half hour or so, all the while wearing ridiculous holiday sweaters and/or holiday headgear, as is now tradition. So, if you are not watching, you may want to switch and find a video option for your viewing pleasure. Watch this episode: https://youtu.be/taqcjqeQQBE Paper Links: Interlaboratory assays from the fungal PCR Initiative and the Modimucor Study Group to improve qPCR detection of Mucorales DNA in serum: one more step toward standardization | Journal of Clinical Microbiology https://journals.asm.org/doi/10.1128/jcm.01525-24 Detection of protozoan and helminth parasites in concentrated wet mounts of stool using a deep convolutional neural network | Journal of Clinical Microbiology https://journals.asm.org/doi/10.1128/jcm.01062-25 Prediction of antimicrobial susceptibility of pneumococci based on whole-genome sequencing data: a direct comparison of two genomic tools to conventional antimicrobial susceptibility testing | Journal of Clinical Microbiology https://journals.asm.org/doi/10.1128/jcm.01079-24 a. Bonus: Rapid detection of gram-negative antimicrobial resistance determinants directly from positive blood culture broths using a multiplex PCR system | Journal of Clinical Microbiology https://journals.asm.org/doi/10.1128/jcm.00384-25 A novel single-tier serologic test to diagnose all stages of Lyme disease | Journal of Clinical Microbiology https://journals.asm.org/doi/10.1128/jcm.00483-25 This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM) and Elitza (Elli) Theel, Ph.D., D(ABMM). Editors in conversation is supported by the American Society for Microbiology, which publishes JCM. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at https://asm.org/joinasm. Visit https://journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Get the audio only podcast at https://asm.org/eic.
Dec 6, 2025 · 47 min
Clinical Trials With the Potential To Change the Management of Prosthetic Joint Infections
Prosthetic joint infections (PJI) remain among the most devastating complications in orthopedic surgery, with increasing incidence paralleling the growth in arthroplasty procedures worldwide. While treatment protocols are well-established, evidence supporting current approaches is lacking, and outcomes remain suboptimal, highlighting the need for improved therapeutic strategies. AAC recently published a minireview of randomized controlled trials and emerging evidence for the management for these difficult to treat infection. Today, we discuss with one of the authors of the manuscript and an ID doctor specialized in PJI infections the findings of such paper. Topics discussed: Challenges of treating prosthetic joint infections. Major clinical trial data supporting different approaches for treatment and prevention of PJI Guidance for the approach to these complicated infections. Guests: David Paterson MBBS, Ph.D., Professor, Saw Swee Hock School of Public Health (Joint) Yong Loo Lin School of Public Health (Joint), Director, ADVANCE-ID, National University of Singapore, Singapore. Ana Victoria Salas-Vargas, M.D. Assistant Professor of Clinical Medicine, Houston Methodist Academic Institute and Weill Cornell Medical College. Links: Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidence https://doi.org/10.1128/aac.00338-25 This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal. Visit asm.org/aac to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.
Nov 20, 2025 · 44 min
Metabolomics
It's that time of year, folks! No, not leaf-peeping season, or pumpkin spice season or even apple picking season – I'm talking respiratory virus season! The symphony of sniffles and coughs is just around the corner! It's the time of year that clinical laboratories are stocking up on supplies, developing testing algorithms and putting out communications to try to convince people that every kid with the sniffles does not, in fact, warrant a highly-multiplexed respiratory virus panel test. The diagnostic landscape for respiratory viruses has evolved dramatically in the last five years, with widespread institution of molecular tests both in laboratories of all sizes, but also at the point of care – and even consumer direct testing. What's next for respiratory virus testing? Watch this episode: https://youtu.be/_tXqLyV3-QE
Oct 25, 2025 · 36 min
The First OTC Syphilis Test: Clinical Performance and Impact
Treponema pallidum, the causative agent of syphilis, has been around for what seems like forever, causing major outbreaks throughout the millennia and continuing to spread at high rates, globally, into today. When it comes to diagnostic testing, some tests like RPR and VDRL have stood the test of time, having been implemented in the late 1930s and 1940s, and are now used in combination with contemporary methods like EIAs and chemiluminescent assays as the reference standard method to diagnosis syphilis cases. New approaches to screening and diagnosis are needed, however, to increase test access and ultimately case identification and treatment. Guests: Dr. Kevin Clark Dr. Jody Berry Links: Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM). Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.
Oct 14, 2025 · 38 min
Artificial Intelligence in the Microbiology Laboratory (JCM ed.)
The launch of ChatGPT three years ago brought the concept of artificial intelligence into the daily conversation. Today, it seems all industries, including lab medicine, are integrating AI with the promise of making our lives easier. How do we best navigate implementing this technology into clinical microbiology? How will it be regulated? … and, what is AI anyway? Watch this epsiode: https://youtu.be/2B_JJEFJv7I Guests: Dr. Susan Sharp Dr. Kendall Bryant Links: Proceedings of the Clinical Microbiology Open 2024: artificial intelligence applications in clinical microbiology Diagnosis of Plasmodium infections using artificial intelligence techniques versus standard microscopy in a reference laboratory Development and evaluation of an artificial intelligence for bacterial growth monitoring in clinical bacteriology This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM). Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.
Sep 29, 2025 · 14 min
What Makes a Great Mini-review? (JCM ed.)
The Journal of Clinical Microbiology has a great tradition of publishing mini-reviews on topics that are important to the clinical microbiology community. Minireviews provide "up to the minute" updates on topics pertinent to clinical microbiologists and serve as fabulous training tools for medical professionals, trainees, and researchers across all disciplines. Dr. Humphries and Dr. Ledeboer discuss what makes a great mini-review, and their favorite mini-reviews published in JCM. Watch this episode: https://youtu.be/sXOrfTkoDGM This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM). Editors in conversation is supported by the American Society for Microbiology, which publishes JCM. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at https://asm.org/joinasm. Visit https://journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Subscribe to the podcast at https://asm.org/eic
Sep 17, 2025 · 39 min
Emerging Technologies for Rapid Phenotypic AST of Clinical Isolates of Bacteria (JCM ed.)
Antimicrobial resistance is one of the largest threats to global public health, compromising all other advances in modern medicine. At the forefront of detecting AMR is the clinical laboratory. However, walk into any clinical microbiology laboratory today and you will find this important task being accomplished using techniques that barely evolved from the methods proposed by Alexander Fleming, nearly 100 years ago. Bacteria are exposed to antimicrobials, in an in vitro culture system, and growth inhibition is measured after overnight incubation. In the time of laboratory automation, molecular testing and artificial intelligence – are we ready for an antimicrobial susceptibility testing revolution? What are the technologies that might get us there? Guests: Dr. Daniel Rhodes Dr. Jacob Rattin Article Link: https://journals.asm.org/doi/10.1128/jcm.00674-25 This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM) and Elitza (Elli) Theel, Ph.D., D(ABMM). JCM is available at jcm.asm.org. Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.